Business Context and Reporting Period
Company: Pacific Biosciences of California, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 15, 2017
Event: Entry into a Material Definitive Agreement regarding a public offering of common stock.
Key Financial Metrics
This filing reports on a capital raise event rather than operational financial performance. Specific metrics include:
- Shares Offered: 15,419,354 shares of common stock.
- Offering Price: $3.10 per share.
- Over-Allotment Option: Underwriters exercised a full option to purchase an additional 2,312,903 shares.
- Total Shares Sold: 17,732,257 shares (including option exercise).
- Net Proceeds: Approximately $52.4 million (after underwriting discounts and estimated offering expenses).
- Underwriter: Cantor Fitzgerald & Co. (representative).
Material Changes
The primary material change is the increase in the company's cash liquidity through the completion of the offering on June 20, 2017. The filing does not provide comparative operational data (revenue, profit, or margins) against prior periods as it is a transactional report.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the pricing and closing of the offering but does not contain forward-looking guidance on revenue or earnings.
Risks and Contingencies: The Underwriting Agreement includes customary representations, warranties, and indemnification provisions where the Company agreed to indemnify the Underwriters against certain liabilities. The filing notes that the agreement's terms are qualified by reference to the full document filed as Exhibit 1.1.
Investor Verification Checklist
- Verify the final closing date of the offering (June 20, 2017) and the exact net proceeds received.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification liabilities and covenants.
- Confirm the dilution impact of the 17,732,257 newly issued shares on existing shareholders.
- Check the company's subsequent filings (e.g., 10-Q or 10-K) to see how the $52.4 million in proceeds was utilized.